Continuing efforts to obtain continuous delivery of levodopa
Identifieur interne : 001736 ( Main/Exploration ); précédent : 001735; suivant : 001737Continuing efforts to obtain continuous delivery of levodopa
Auteurs : Jose A. Obeso [Espagne] ; Warren Olanow [États-Unis]Source :
- Movement Disorders [ 0885-3185 ] ; 2011-10.
English descriptors
- KwdEn :
- MESH :
- chemical , administration & dosage : Dopamine Agents, Levodopa.
- chemical , blood : Dopamine Agents, Levodopa.
- blood : Parkinson Disease.
- drug therapy : Parkinson Disease.
- Animals, Chemistry, Pharmaceutical, Drug Delivery Systems, Humans.
Url:
DOI: 10.1002/mds.23996
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 003C94
- to stream Istex, to step Curation: 003C94
- to stream Istex, to step Checkpoint: 000469
- to stream PubMed, to step Corpus: 000F95
- to stream PubMed, to step Curation: 000F95
- to stream PubMed, to step Checkpoint: 001406
- to stream Ncbi, to step Merge: 003435
- to stream Ncbi, to step Curation: 003435
- to stream Ncbi, to step Checkpoint: 003435
- to stream Main, to step Merge: 001790
- to stream Main, to step Curation: 001736
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Continuing efforts to obtain continuous delivery of levodopa</title><author><name sortKey="Obeso, Jose A" sort="Obeso, Jose A" uniqKey="Obeso J" first="Jose A." last="Obeso">Jose A. Obeso</name></author><author><name sortKey="Olanow, Warren" sort="Olanow, Warren" uniqKey="Olanow W" first="Warren" last="Olanow">Warren Olanow</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:5466FB15D712F9E926CFDA20E456705D7B1C29D8</idno><date when="2011" year="2011">2011</date><idno type="doi">10.1002/mds.23996</idno><idno type="url">https://api.istex.fr/document/5466FB15D712F9E926CFDA20E456705D7B1C29D8/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">003C94</idno><idno type="wicri:Area/Istex/Curation">003C94</idno><idno type="wicri:Area/Istex/Checkpoint">000469</idno><idno type="wicri:doubleKey">0885-3185:2011:Obeso J:continuing:efforts:to</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:22021155</idno><idno type="wicri:Area/PubMed/Corpus">000F95</idno><idno type="wicri:Area/PubMed/Curation">000F95</idno><idno type="wicri:Area/PubMed/Checkpoint">001406</idno><idno type="wicri:Area/Ncbi/Merge">003435</idno><idno type="wicri:Area/Ncbi/Curation">003435</idno><idno type="wicri:Area/Ncbi/Checkpoint">003435</idno><idno type="wicri:Area/Main/Merge">001790</idno><idno type="wicri:Area/Main/Curation">001736</idno><idno type="wicri:Area/Main/Exploration">001736</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Continuing efforts to obtain continuous delivery of levodopa</title><author><name sortKey="Obeso, Jose A" sort="Obeso, Jose A" uniqKey="Obeso J" first="Jose A." last="Obeso">Jose A. Obeso</name><affiliation wicri:level="1"><country xml:lang="fr">Espagne</country><wicri:regionArea>Department of Neurology, University of Navarra, Pamplona</wicri:regionArea><wicri:noRegion>Pamplona</wicri:noRegion></affiliation></author><author><name sortKey="Olanow, Warren" sort="Olanow, Warren" uniqKey="Olanow W" first="Warren" last="Olanow">Warren Olanow</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Departments of Neurology and Neuroscience, Mount Sinai School of Medicine, New York, New York</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2011-10">2011-10</date><biblScope unit="vol">26</biblScope><biblScope unit="issue">12</biblScope><biblScope unit="page" from="2149">2149</biblScope><biblScope unit="page" to="2150">2150</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">5466FB15D712F9E926CFDA20E456705D7B1C29D8</idno><idno type="DOI">10.1002/mds.23996</idno><idno type="ArticleID">MDS23996</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term><term>Chemistry, Pharmaceutical</term><term>Dopamine Agents (administration & dosage)</term><term>Dopamine Agents (blood)</term><term>Drug Delivery Systems</term><term>Humans</term><term>Levodopa (administration & dosage)</term><term>Levodopa (blood)</term><term>Parkinson Disease (blood)</term><term>Parkinson Disease (drug therapy)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Dopamine Agents</term><term>Levodopa</term></keywords><keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Dopamine Agents</term><term>Levodopa</term></keywords><keywords scheme="MESH" qualifier="blood" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Chemistry, Pharmaceutical</term><term>Drug Delivery Systems</term><term>Humans</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader></TEI><affiliations><list><country><li>Espagne</li><li>États-Unis</li></country><region><li>État de New York</li></region></list><tree><country name="Espagne"><noRegion><name sortKey="Obeso, Jose A" sort="Obeso, Jose A" uniqKey="Obeso J" first="Jose A." last="Obeso">Jose A. Obeso</name></noRegion></country><country name="États-Unis"><region name="État de New York"><name sortKey="Olanow, Warren" sort="Olanow, Warren" uniqKey="Olanow W" first="Warren" last="Olanow">Warren Olanow</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001736 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001736 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:5466FB15D712F9E926CFDA20E456705D7B1C29D8
|texte= Continuing efforts to obtain continuous delivery of levodopa
}}
| This area was generated with Dilib version V0.6.23. |  |